ZimVie Inc. Company Analysis & Research
ZimVie develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company completed the sale of its Spine business to become a pure-play dental company focused on dental implants, biomaterials, and digital dentistry. As of mid-2025, ZimVie has entered into a definitive agreement to be acquired by an affiliate of ARCHIMED for $19.00 in cash per share, with the transaction expected to close by year-end 2025.
The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products; and patient-specific restorative solutions under the BellaTek brand name. ZimVie has developed advanced digital workflows that empower clinicians to plan, design, and implement surgical procedures with enhanced accuracy, such as the RealGUIDE® Dental Implant Software Suite with one-click nerve detection capabilities.
Company Overview
Founded: 2021. Headquarters: Palm Beach Gardens, Florida, US. Revenue: $0.45B. Employees: 1770. Market Cap: $0.53B. Ticker: ZIMV (NASDAQ).
Industry
Medical Devices - Dental Implants & Restorative Solutions
Cyborg Score: 5/10 — Mixed
Transitional dental-focused medtech with strong balance sheet improvement but facing growth headwinds and pending takeout at $19.00/share
In 2024, ZimVie's revenue was $449.75 million, a decrease of -1.68% compared to the prior year. The company achieved significant net debt reduction from $437.3M in Q4 2023 to $145.5M in Q4 2024. However, pending acquisition and analyst skepticism regarding growth prospects temper outlook.
Key Strategic Insights for ZimVie Inc.
- Strategic transformation to pure-play dental company completed via spine business divestiture, simplifying operational focus
- Acquired by ARCHIMED at $19/share (pending Q4 2025 close), eliminating public market uncertainty but signaling growth challenges
- Net debt reduced $290M+ in 2024 demonstrating financial discipline and deleveraging execution
- Digital-integrated workflows (RealGUIDE® suite) provide differentiation in increasingly competitive dental implant market
Recent Developments
- (October 2025) Stockholders approved ARCHIMED acquisition for $19.00 per share
- (July 2025) Announced Q2 2025 results and withdrawn fiscal 2025 guidance due to pending acquisition
- (Q1 2025) Reported $112M net sales with net loss of $(2.6)M; Adjusted EBITDA $17.6M
- (2024) Completed spine business sale becoming pure-play dental company with $449.7M revenue
Competitors & Competitive Landscape
- Dentsply Sirona — Leading global dental solutions provider
- Straumann — Premium implant and digital dentistry leader
- Henry Schein — Major dental distributor and solutions provider
ZimVie competes with companies including The Smile Design, Smiles, Ridgetop Dental, and Dentistry of the Carolinas. The dental implant market features major players like Dentsply Sirona and straos Technologies. ZimVie differentiates through its digital workflow integration, proprietary surface technologies, and comprehensive biomaterial solutions for implant procedures.
More Company Research
PermRock Royalty Trust Groupe Minoteries SA Outdoor Holding Company Yiren Digital Limited D2L Inc. AmRest Holdings SE The Commercial Real Estate Company K.P.S.C (Al-Tijaria) Elkem ASA Santam Limited RH (Restoration Hardware Holdings, Inc.) New Hope Liuhe Co., Ltd. Grupo Financiero Galicia S.A. Yum China Holdings, Inc. Denso Corporation Purple Innovation, Inc.Full Company Research Reports
Looking for a more in-depth analysis of ZimVie Inc.? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, analyst debate audio, and saved-company audio playlists.